Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,328 | $725,154 | $739,299 | $771,889 |
| - Cash | $1,233 | $138,991 | $204,567 | $160,982 |
| + Debt | $883 | $138,111 | $146,678 | $154,286 |
| Enterprise Value | $4,978 | $724,274 | $681,410 | $765,193 |
| Revenue | $879 | $127,536 | $112,309 | $134,223 |
| % Growth | -99.3% | 13.6% | -16.3% | – |
| Gross Profit | $642 | $90,523 | $67,072 | $88,387 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | $272 | $31,233 | -$5,788 | $24,045 |
| % Margin | 30.9% | 24.5% | -5.2% | 17.9% |
| Net Income | $153 | $17,673 | -$6,545 | $14,951 |
| % Margin | 17.4% | 13.9% | -5.8% | 11.1% |
| EPS Diluted | 0.11 | 12.53 | -4.66 | 10.6 |
| % Growth | -99.1% | 368.9% | -144% | – |
| Operating Cash Flow | $353 | $3,373 | $38,996 | $63 |
| Capital Expenditures | -$11 | -$2,250 | -$1,421 | -$8 |
| Free Cash Flow | $341 | $1,123 | $37,575 | $55 |